fanta.bio Sample: CNhs11829
18123 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| HIF1A SRX11007095 | HK-2 Kidney | 1669 / 11302 (14.8%) | 717 / 113020 (0.6%) | −324.0 | −324.0 | 23.28 |
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 833 / 11302 (7.4%) | 366 / 113020 (0.3%) | −324.0 | −324.0 | 22.76 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1153 / 11302 (10.2%) | 617 / 113020 (0.5%) | −324.0 | −324.0 | 18.69 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1125 / 11302 (10.0%) | 658 / 113020 (0.6%) | −324.0 | −324.0 | 17.10 |
| SCML2 SRX644728 | 293 Kidney | 981 / 11302 (8.7%) | 603 / 113020 (0.5%) | −324.0 | −324.0 | 16.27 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 1556 / 11302 (13.8%) | 983 / 113020 (0.9%) | −324.0 | −324.0 | 15.83 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 1492 / 11302 (13.2%) | 983 / 113020 (0.9%) | −324.0 | −324.0 | 15.18 |
| FOXP1 SRX736067 | LNCAP Prostate | 1073 / 11302 (9.5%) | 997 / 113020 (0.9%) | −324.0 | −324.0 | 10.76 |
| BRD4 SRX9419935 | BT-474 Breast | 2125 / 11302 (18.8%) | 2229 / 113020 (2.0%) | −324.0 | −324.0 | 9.53 |
| BRD4 SRX9419937 | BT-474 Breast | 2135 / 11302 (18.9%) | 2271 / 113020 (2.0%) | −324.0 | −324.0 | 9.40 |
| MED1 SRX9419945 | BT-474 Breast | 2110 / 11302 (18.7%) | 2256 / 113020 (2.0%) | −324.0 | −324.0 | 9.35 |
| MED1 SRX9419944 | BT-474 Breast | 2030 / 11302 (18.0%) | 2246 / 113020 (2.0%) | −324.0 | −324.0 | 9.04 |
| BRD4 SRX9419936 | BT-474 Breast | 2137 / 11302 (18.9%) | 2368 / 113020 (2.1%) | −324.0 | −324.0 | 9.02 |
| MED1 SRX9419946 | BT-474 Breast | 2118 / 11302 (18.7%) | 2399 / 113020 (2.1%) | −324.0 | −324.0 | 8.83 |
| BRD4 SRX9419938 | BT-474 Breast | 2098 / 11302 (18.6%) | 2389 / 113020 (2.1%) | −324.0 | −324.0 | 8.78 |
| MED1 SRX9419947 | BT-474 Breast | 2043 / 11302 (18.1%) | 2338 / 113020 (2.1%) | −324.0 | −324.0 | 8.74 |
| EZH2 SRX2146136 | LNCAP Prostate | 4650 / 11302 (41.1%) | 6232 / 113020 (5.5%) | −324.0 | −324.0 | 7.46 |
| BRD4 SRX736201 | 90-8TL Neural | 3527 / 11302 (31.2%) | 5038 / 113020 (4.5%) | −324.0 | −324.0 | 7.00 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1193 / 11302 (10.6%) | 1947 / 113020 (1.7%) | −324.0 | −324.0 | 6.13 |
| MYH11 SRX265221 | ME-1 Blood | 541 / 11302 (4.8%) | 503 / 113020 (0.4%) | −276.1 | −272.9 | 10.76 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1052 / 11302 (9.3%) | 2556 / 113020 (2.3%) | −269.0 | −265.8 | 4.12 |
| TP53 SRX19538279 | Osteoblasts Bone | 392 / 11302 (3.5%) | 192 / 113020 (0.2%) | −259.4 | −256.3 | 20.42 |
| TP53 SRX19538268 | U2OS Bone | 330 / 11302 (2.9%) | 124 / 113020 (0.1%) | −236.3 | −233.2 | 26.61 |
| TP53 SRX19538274 | U2OS Bone | 329 / 11302 (2.9%) | 125 / 113020 (0.1%) | −234.9 | −231.7 | 26.32 |
| TP53 SRX19538276 | U2OS Bone | 330 / 11302 (2.9%) | 128 / 113020 (0.1%) | −234.3 | −231.1 | 25.78 |
| HIF1A SRX20663235 | HK-2 Kidney | 356 / 11302 (3.1%) | 212 / 113020 (0.2%) | −220.0 | −216.8 | 16.79 |
| TP53 SRX19538280 | Osteoblasts Bone | 323 / 11302 (2.9%) | 145 / 113020 (0.1%) | −219.6 | −216.5 | 22.28 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1138 / 11302 (10.1%) | 3527 / 113020 (3.1%) | −218.6 | −215.5 | 3.23 |
| TP53 SRX19538273 | U2OS Bone | 295 / 11302 (2.6%) | 109 / 113020 (0.1%) | −212.2 | −209.1 | 27.06 |
| TP53 SRX19538267 | U2OS Bone | 297 / 11302 (2.6%) | 114 / 113020 (0.1%) | −211.4 | −208.4 | 26.05 |
| AGO2 SRX4708039 | Hep G2 Liver | 1393 / 11302 (12.3%) | 5122 / 113020 (4.5%) | −210.6 | −207.6 | 2.72 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 507 / 11302 (4.5%) | 676 / 113020 (0.6%) | −210.1 | −207.1 | 7.50 |
| TP53 SRX19538269 | U2OS Bone | 372 / 11302 (3.3%) | 283 / 113020 (0.3%) | −208.1 | −205.1 | 13.14 |
| TP53 SRX19538281 | Osteoblasts Bone | 338 / 11302 (3.0%) | 206 / 113020 (0.2%) | −207.0 | −204.0 | 16.41 |
| TP53 SRX19538275 | U2OS Bone | 297 / 11302 (2.6%) | 123 / 113020 (0.1%) | −206.9 | −203.9 | 24.15 |
| IRF3 SRX11453858 | Hep G2 Liver | 264 / 11302 (2.3%) | 69 / 113020 (0.1%) | −206.4 | −203.4 | 38.26 |
| KAT6A SRX20971022 | Fibroblasts Others | 254 / 11302 (2.2%) | 57 / 113020 (0.1%) | −204.8 | −201.9 | 44.56 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 316 / 11302 (2.8%) | 169 / 113020 (0.1%) | −202.9 | −199.9 | 18.70 |
| PBX4 SRX2731658 | PC-3 Prostate | 674 / 11302 (6.0%) | 17483 / 113020 (15.5%) | −198.5 | −195.6 | 0.39 |
| TP53 SRX19538270 | U2OS Bone | 346 / 11302 (3.1%) | 290 / 113020 (0.3%) | −185.2 | −182.3 | 11.93 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 467 / 11302 (4.1%) | 681 / 113020 (0.6%) | −182.0 | −179.1 | 6.86 |
| IRF3 SRX11453861 | Hep G2 Liver | 233 / 11302 (2.1%) | 64 / 113020 (0.1%) | −180.2 | −177.3 | 36.41 |
| FOS SRX150478 | MCF 10A Breast | 461 / 11302 (4.1%) | 13477 / 113020 (11.9%) | −175.0 | −172.1 | 0.34 |
| BRD4 SRX736204 | 90-8TL Neural | 737 / 11302 (6.5%) | 1920 / 113020 (1.7%) | −172.6 | −169.8 | 3.84 |
| FOS SRX150477 | MCF 10A Breast | 449 / 11302 (4.0%) | 13139 / 113020 (11.6%) | −170.4 | −167.5 | 0.34 |
| YAP1 SRX757325 | H2052 Lung | 480 / 11302 (4.2%) | 13504 / 113020 (11.9%) | −166.9 | −164.1 | 0.36 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 1478 / 11302 (13.1%) | 6532 / 113020 (5.8%) | −160.7 | −157.9 | 2.26 |
| RUNX1 SRX2513054 | 293 Kidney | 2241 / 11302 (19.8%) | 12044 / 113020 (10.7%) | −160.3 | −157.5 | 1.86 |
| TP53 SRX19538282 | Osteoblasts Bone | 283 / 11302 (2.5%) | 210 / 113020 (0.2%) | −160.0 | −157.1 | 13.48 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1025 / 11302 (9.1%) | 3696 / 113020 (3.3%) | −157.2 | −154.4 | 2.77 |
| YAP1 SRX757326 | H2052 Lung | 413 / 11302 (3.7%) | 12067 / 113020 (10.7%) | −155.2 | −152.4 | 0.34 |
| AGO2 SRX6783958 | Hep G2 Liver | 903 / 11302 (8.0%) | 3023 / 113020 (2.7%) | −154.3 | −151.4 | 2.99 |
| TP53 SRX19538271 | U2OS Bone | 454 / 11302 (4.0%) | 816 / 113020 (0.7%) | −151.0 | −148.2 | 5.56 |
| AR SRX10820653 | LNCAP Prostate | 250 / 11302 (2.2%) | 158 / 113020 (0.1%) | −150.9 | −148.2 | 15.82 |
| AGO2 SRX6783957 | Hep G2 Liver | 907 / 11302 (8.0%) | 3097 / 113020 (2.7%) | −150.5 | −147.7 | 2.93 |
| FOS SRX4192880 | MCF 10A Breast | 343 / 11302 (3.0%) | 10690 / 113020 (9.5%) | −147.2 | −144.4 | 0.32 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 417 / 11302 (3.7%) | 721 / 113020 (0.6%) | −143.0 | −140.3 | 5.78 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 1369 / 11302 (12.1%) | 6169 / 113020 (5.5%) | −142.0 | −139.2 | 2.22 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 461 / 11302 (4.1%) | 919 / 113020 (0.8%) | −140.3 | −137.6 | 5.02 |
| CIC SRX13262055 | Astrocytes Neural | 2064 / 11302 (18.3%) | 11319 / 113020 (10.0%) | −137.9 | −135.1 | 1.82 |
| SREBF2 SRX5359048 | HCC70 Breast | 1202 / 11302 (10.6%) | 5148 / 113020 (4.6%) | −137.2 | −134.5 | 2.33 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1169 / 11302 (10.3%) | 4947 / 113020 (4.4%) | −136.4 | −133.7 | 2.36 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 1367 / 11302 (12.1%) | 6284 / 113020 (5.6%) | −136.0 | −133.3 | 2.18 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 1284 / 11302 (11.4%) | 5717 / 113020 (5.1%) | −136.0 | −133.3 | 2.25 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1213 / 11302 (10.7%) | 5265 / 113020 (4.7%) | −134.9 | −132.2 | 2.30 |
| Epitope tags SRX10549776 | K-562 Blood | 954 / 11302 (8.4%) | 3628 / 113020 (3.2%) | −133.6 | −130.9 | 2.63 |
| FOS SRX150517 | MCF 10A Breast | 369 / 11302 (3.3%) | 10628 / 113020 (9.4%) | −132.9 | −130.2 | 0.35 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 482 / 11302 (4.3%) | 12347 / 113020 (10.9%) | −132.9 | −130.2 | 0.39 |
| FOXA1 SRX4815198 | MCF-7 Breast | 759 / 11302 (6.7%) | 16166 / 113020 (14.3%) | −129.9 | −127.2 | 0.47 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 1215 / 11302 (10.8%) | 5385 / 113020 (4.8%) | −129.6 | −126.9 | 2.26 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 1258 / 11302 (11.1%) | 5689 / 113020 (5.0%) | −128.9 | −126.2 | 2.21 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1104 / 11302 (9.8%) | 4671 / 113020 (4.1%) | −128.4 | −125.7 | 2.36 |
| PTEN SRX5416007 | SMMC-7721 Liver | 1253 / 11302 (11.1%) | 5715 / 113020 (5.1%) | −126.0 | −123.3 | 2.19 |
| AR SRX1067071 | LHSAR Prostate | 443 / 11302 (3.9%) | 11500 / 113020 (10.2%) | −125.4 | −122.8 | 0.39 |
| AR SRX10820651 | LNCAP Prostate | 250 / 11302 (2.2%) | 240 / 113020 (0.2%) | −125.1 | −122.5 | 10.42 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 447 / 11302 (4.0%) | 979 / 113020 (0.9%) | −124.6 | −122.0 | 4.57 |
| FOS SRX150476 | MCF 10A Breast | 394 / 11302 (3.5%) | 10711 / 113020 (9.5%) | −124.2 | −121.5 | 0.37 |
| CDYL2 SRX8321653 | MCF-7 Breast | 1265 / 11302 (11.2%) | 5847 / 113020 (5.2%) | −123.6 | −121.0 | 2.16 |
| 5-mC SRX882970 | LNCAP Prostate | 1870 / 11302 (16.5%) | 10313 / 113020 (9.1%) | −121.4 | −118.7 | 1.81 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 183 / 11302 (1.6%) | 92 / 113020 (0.1%) | −120.1 | −117.4 | 19.89 |
| TRIM25 SRX1660872 | Breast cancer cells Breast | 1153 / 11302 (10.2%) | 5169 / 113020 (4.6%) | −119.6 | −117.0 | 2.23 |
| ESR1 SRX4367193 | MCF-7 Breast | 759 / 11302 (6.7%) | 15734 / 113020 (13.9%) | −119.3 | −116.7 | 0.48 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 184 / 11302 (1.6%) | 96 / 113020 (0.1%) | −119.2 | −116.6 | 19.17 |
| FOXA1 SRX4815197 | MCF-7 Breast | 571 / 11302 (5.1%) | 13100 / 113020 (11.6%) | −118.4 | −115.8 | 0.44 |
| ESR1 SRX7624157 | MCF-7 Breast | 612 / 11302 (5.4%) | 13677 / 113020 (12.1%) | −118.4 | −115.8 | 0.45 |
| JUN SRX17561461 | LPS141 Adipocyte | 330 / 11302 (2.9%) | 9515 / 113020 (8.4%) | −118.4 | −115.8 | 0.35 |
| JUNB SRX8488088 | SUM 229PE Breast | 450 / 11302 (4.0%) | 11338 / 113020 (10.0%) | −118.2 | −115.6 | 0.40 |
| KAT7 SRX101303 | RKO Digestive tract | 899 / 11302 (8.0%) | 3545 / 113020 (3.1%) | −118.0 | −115.5 | 2.54 |
| BRD1 SRX286203 | RKO Digestive tract | 790 / 11302 (7.0%) | 2881 / 113020 (2.5%) | −117.8 | −115.3 | 2.74 |
| MECOM SRX23677897 | HNT-34 Blood | 1390 / 11302 (12.3%) | 6862 / 113020 (6.1%) | −117.5 | −114.9 | 2.03 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 168 / 11302 (1.5%) | 6766 / 113020 (6.0%) | −117.4 | −114.9 | 0.25 |
| TP53 SRX396254 | Fibroblasts Others | 619 / 11302 (5.5%) | 1910 / 113020 (1.7%) | −117.3 | −114.8 | 3.24 |
| MECOM SRX23677896 | HNT-34 Blood | 1438 / 11302 (12.7%) | 7216 / 113020 (6.4%) | −117.2 | −114.6 | 1.99 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 782 / 11302 (6.9%) | 2847 / 113020 (2.5%) | −117.0 | −114.4 | 2.75 |
| BMI1 SRX644729 | 293 Kidney | 184 / 11302 (1.6%) | 102 / 113020 (0.1%) | −116.7 | −114.2 | 18.04 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 791 / 11302 (7.0%) | 16051 / 113020 (14.2%) | −116.6 | −114.0 | 0.49 |
| MECOM SRX23677885 | HNT-34 Blood | 1198 / 11302 (10.6%) | 5540 / 113020 (4.9%) | −116.5 | −114.0 | 2.16 |
| ESR1 SRX371478 | MCF-7 Breast | 307 / 11302 (2.7%) | 9068 / 113020 (8.0%) | −116.0 | −113.4 | 0.34 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 480 / 11302 (4.2%) | 1212 / 113020 (1.1%) | −115.6 | −113.1 | 3.96 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 231 / 11302 (2.0%) | 7814 / 113020 (6.9%) | −115.6 | −113.1 | 0.30 |
| BMI1 SRX7196721 | SF8628 Neural | 1165 / 11302 (10.3%) | 5343 / 113020 (4.7%) | −115.2 | −112.7 | 2.18 |
| FOXA1 SRX176862 | MCF-7 Breast | 319 / 11302 (2.8%) | 9199 / 113020 (8.1%) | −114.3 | −111.8 | 0.35 |
| TP53 SRX19538272 | U2OS Bone | 377 / 11302 (3.3%) | 763 / 113020 (0.7%) | −113.1 | −110.6 | 4.94 |
| BRPF3 SRX796084 | RKO Digestive tract | 990 / 11302 (8.8%) | 4216 / 113020 (3.7%) | −113.0 | −110.5 | 2.35 |
| LEO1 SRX1873456 | SEM Blood | 987 / 11302 (8.7%) | 4201 / 113020 (3.7%) | −112.9 | −110.4 | 2.35 |
| KMT2A SRX2323891 | 293 Kidney | 680 / 11302 (6.0%) | 2309 / 113020 (2.0%) | −112.7 | −110.2 | 2.94 |
| MECOM SRX23677884 | HNT-34 Blood | 1169 / 11302 (10.3%) | 5445 / 113020 (4.8%) | −111.7 | −109.3 | 2.15 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 609 / 11302 (5.4%) | 1927 / 113020 (1.7%) | −111.5 | −109.0 | 3.16 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 286 / 11302 (2.5%) | 8580 / 113020 (7.6%) | −111.5 | −109.0 | 0.33 |
| 5-mC SRX882968 | LNCAP Prostate | 1818 / 11302 (16.1%) | 10217 / 113020 (9.0%) | −111.2 | −108.7 | 1.78 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 797 / 11302 (7.1%) | 15883 / 113020 (14.1%) | −110.7 | −108.2 | 0.50 |
| FOS SRX4192879 | MCF 10A Breast | 273 / 11302 (2.4%) | 8339 / 113020 (7.4%) | −110.5 | −108.1 | 0.33 |
| ESR1 SRX371479 | MCF-7 Breast | 226 / 11302 (2.0%) | 7562 / 113020 (6.7%) | −110.4 | −108.0 | 0.30 |
| ESR1 SRX371469 | MCF-7 Breast | 255 / 11302 (2.3%) | 8039 / 113020 (7.1%) | −110.4 | −107.9 | 0.32 |
| RELA SRX2207673 | HUVEC Cardiovascular | 865 / 11302 (7.7%) | 16764 / 113020 (14.8%) | −110.3 | −107.8 | 0.52 |
| ERG SRX063922 | K-562 Blood | 1063 / 11302 (9.4%) | 4761 / 113020 (4.2%) | −110.1 | −107.6 | 2.23 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 302 / 11302 (2.7%) | 8786 / 113020 (7.8%) | −110.1 | −107.6 | 0.34 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 848 / 11302 (7.5%) | 3362 / 113020 (3.0%) | −110.1 | −107.6 | 2.52 |
| 5-mC SRX882965 | LNCAP Prostate | 1515 / 11302 (13.4%) | 7961 / 113020 (7.0%) | −110.0 | −107.6 | 1.90 |
| FOXA1 SRX176863 | MCF-7 Breast | 302 / 11302 (2.7%) | 8780 / 113020 (7.8%) | −109.9 | −107.5 | 0.34 |
| RORC SRX5359053 | HCC70 Breast | 849 / 11302 (7.5%) | 3383 / 113020 (3.0%) | −109.2 | −106.7 | 2.51 |
| FOXA1 SRX1161177 | MCF-7 Breast | 255 / 11302 (2.3%) | 7988 / 113020 (7.1%) | −108.8 | −106.4 | 0.32 |
| FOXA1 SRX3931044 | MCF-7 Breast | 534 / 11302 (4.7%) | 12201 / 113020 (10.8%) | −108.8 | −106.4 | 0.44 |
| ESR1 SRX7624156 | MCF-7 Breast | 403 / 11302 (3.6%) | 10282 / 113020 (9.1%) | −108.5 | −106.1 | 0.39 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 218 / 11302 (1.9%) | 7360 / 113020 (6.5%) | −108.4 | −106.0 | 0.30 |
| RORC SRX5359052 | HCC70 Breast | 879 / 11302 (7.8%) | 3586 / 113020 (3.2%) | −108.3 | −105.9 | 2.45 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 287 / 11302 (2.5%) | 8482 / 113020 (7.5%) | −108.2 | −105.8 | 0.34 |
| ESR1 SRX20282961 | MCF-7 Breast | 322 / 11302 (2.8%) | 9030 / 113020 (8.0%) | −108.0 | −105.6 | 0.36 |
| ERG SRX063921 | K-562 Blood | 1007 / 11302 (8.9%) | 4430 / 113020 (3.9%) | −108.0 | −105.5 | 2.27 |
| STAT5B SRX831881 | CD8+ T cells Blood | 175 / 11302 (1.5%) | 105 / 113020 (0.1%) | −107.9 | −105.5 | 16.67 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 585 / 11302 (5.2%) | 12877 / 113020 (11.4%) | −107.8 | −105.4 | 0.45 |
| TRP47 SRX4548329 | THP-1 Blood | 1698 / 11302 (15.0%) | 9408 / 113020 (8.3%) | −107.6 | −105.2 | 1.80 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 531 / 11302 (4.7%) | 1556 / 113020 (1.4%) | −107.4 | −105.0 | 3.41 |
| BRPF3 SRX796085 | RKO Digestive tract | 705 / 11302 (6.2%) | 2541 / 113020 (2.2%) | −106.8 | −104.4 | 2.77 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 530 / 11302 (4.7%) | 1559 / 113020 (1.4%) | −106.7 | −104.3 | 3.40 |
| ING5 SRX286202 | RKO Digestive tract | 876 / 11302 (7.8%) | 3599 / 113020 (3.2%) | −106.7 | −104.3 | 2.43 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 296 / 11302 (2.6%) | 480 / 113020 (0.4%) | −106.6 | −104.2 | 6.17 |
| RELA SRX2207672 | HUVEC Cardiovascular | 947 / 11302 (8.4%) | 17610 / 113020 (15.6%) | −105.5 | −103.1 | 0.54 |
| ESR1 SRX176860 | MCF-7 Breast | 420 / 11302 (3.7%) | 10407 / 113020 (9.2%) | −105.1 | −102.7 | 0.40 |
| ESR1 SRX176861 | MCF-7 Breast | 417 / 11302 (3.7%) | 10354 / 113020 (9.2%) | −104.8 | −102.4 | 0.40 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 508 / 11302 (4.5%) | 1466 / 113020 (1.3%) | −104.7 | −102.3 | 3.47 |
| GATA3 SRX190239 | MCF-7 Breast | 378 / 11302 (3.3%) | 9761 / 113020 (8.6%) | −104.6 | −102.2 | 0.39 |
| MEAF6 DRX234811 | 293 Kidney | 1092 / 11302 (9.7%) | 5079 / 113020 (4.5%) | −104.3 | −101.9 | 2.15 |
| MITF SRX1555436 | 501A Epidermis | 1280 / 11302 (11.3%) | 6411 / 113020 (5.7%) | −103.9 | −101.6 | 2.00 |
| SMARCA4 SRX5212366 | Mel270 Others | 332 / 11302 (2.9%) | 9036 / 113020 (8.0%) | −103.8 | −101.4 | 0.37 |
| AR SRX1067070 | LHSAR Prostate | 608 / 11302 (5.4%) | 13030 / 113020 (11.5%) | −103.7 | −101.3 | 0.47 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 431 / 11302 (3.8%) | 10504 / 113020 (9.3%) | −103.3 | −101.0 | 0.41 |
| BRPF3 SRX796086 | RKO Digestive tract | 936 / 11302 (8.3%) | 4061 / 113020 (3.6%) | −102.9 | −100.5 | 2.30 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 325 / 11302 (2.9%) | 8890 / 113020 (7.9%) | −102.8 | −100.5 | 0.37 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 531 / 11302 (4.7%) | 11921 / 113020 (10.5%) | −102.8 | −100.5 | 0.45 |
| ESR1 SRX194569 | MCF-7 Breast | 269 / 11302 (2.4%) | 8005 / 113020 (7.1%) | −102.7 | −100.4 | 0.34 |
| ESR1 SRX371467 | MCF-7 Breast | 270 / 11302 (2.4%) | 8000 / 113020 (7.1%) | −102.0 | −99.7 | 0.34 |
| RUNX1 SRX2014504 | Jurkat Blood | 1576 / 11302 (13.9%) | 8653 / 113020 (7.7%) | −101.7 | −99.3 | 1.82 |
| SMARCA4 SRX5212362 | Mel270 Others | 440 / 11302 (3.9%) | 10562 / 113020 (9.3%) | −101.4 | −99.1 | 0.42 |
| MECOM SRX23677890 | HNT-34 Blood | 1184 / 11302 (10.5%) | 5800 / 113020 (5.1%) | −100.9 | −98.6 | 2.04 |
| JUNB SRX10119386 | MCF 10A Breast | 226 / 11302 (2.0%) | 7243 / 113020 (6.4%) | −100.8 | −98.5 | 0.31 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 1239 / 11302 (11.0%) | 6199 / 113020 (5.5%) | −100.6 | −98.3 | 2.00 |
| MEAF6 DRX300417 | 293 Kidney | 999 / 11302 (8.8%) | 4529 / 113020 (4.0%) | −100.4 | −98.1 | 2.21 |
| ESR1 SRX20282960 | MCF-7 Breast | 307 / 11302 (2.7%) | 8522 / 113020 (7.5%) | −100.4 | −98.0 | 0.36 |
| TLE3 SRX4815191 | MCF-7 Breast | 252 / 11302 (2.2%) | 7646 / 113020 (6.8%) | −100.1 | −97.8 | 0.33 |
| FOXA1 SRX371481 | MCF-7 Breast | 282 / 11302 (2.5%) | 8112 / 113020 (7.2%) | −99.8 | −97.5 | 0.35 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 539 / 11302 (4.8%) | 1691 / 113020 (1.5%) | −99.7 | −97.4 | 3.19 |
| Epitope tags DRX443510 | 293 Kidney | 942 / 11302 (8.3%) | 4177 / 113020 (3.7%) | −98.9 | −96.6 | 2.26 |
| FOXA1 SRX371483 | MCF-7 Breast | 304 / 11302 (2.7%) | 8422 / 113020 (7.5%) | −98.7 | −96.4 | 0.36 |
| MECOM SRX23677891 | HNT-34 Blood | 1179 / 11302 (10.4%) | 5820 / 113020 (5.1%) | −98.6 | −96.3 | 2.03 |
| JUN SRX4192884 | MCF 10A Breast | 213 / 11302 (1.9%) | 6952 / 113020 (6.2%) | −98.6 | −96.3 | 0.31 |
| SSRP1 SRX3436567 | HT-1080 Bone | 269 / 11302 (2.4%) | 430 / 113020 (0.4%) | −98.0 | −95.7 | 6.26 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 363 / 11302 (3.2%) | 9276 / 113020 (8.2%) | −97.5 | −95.2 | 0.39 |
| ESR1 SRX371476 | MCF-7 Breast | 201 / 11302 (1.8%) | 6710 / 113020 (5.9%) | −97.4 | −95.1 | 0.30 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 378 / 11302 (3.3%) | 9492 / 113020 (8.4%) | −97.2 | −94.9 | 0.40 |
| JUNB SRX8488073 | SUM 229PE Breast | 481 / 11302 (4.3%) | 10990 / 113020 (9.7%) | −97.2 | −94.9 | 0.44 |
| JUNB SRX8488089 | SUM 229PE Breast | 258 / 11302 (2.3%) | 7624 / 113020 (6.7%) | −96.8 | −94.5 | 0.34 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 292 / 11302 (2.6%) | 528 / 113020 (0.5%) | −96.5 | −94.2 | 5.53 |
| SFPQ SRX593748 | MCF-7 Breast | 1861 / 11302 (16.5%) | 11027 / 113020 (9.8%) | −96.4 | −94.2 | 1.69 |
| JUN SRX883584 | MDA-MB-231 Breast | 405 / 11302 (3.6%) | 9857 / 113020 (8.7%) | −96.4 | −94.1 | 0.41 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 499 / 11302 (4.4%) | 11212 / 113020 (9.9%) | −96.4 | −94.1 | 0.45 |
| FOXA1 SRX371482 | MCF-7 Breast | 392 / 11302 (3.5%) | 9659 / 113020 (8.5%) | −96.3 | −94.0 | 0.41 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 386 / 11302 (3.4%) | 9566 / 113020 (8.5%) | −96.1 | −93.9 | 0.40 |
| FOXA1 SRX1161173 | MCF-7 Breast | 221 / 11302 (2.0%) | 6994 / 113020 (6.2%) | −95.9 | −93.7 | 0.32 |
| GRHL3 SRX2582162 | NHEK Epidermis | 701 / 11302 (6.2%) | 2690 / 113020 (2.4%) | −95.8 | −93.5 | 2.61 |
| FOXA1 SRX1161176 | MCF-7 Breast | 265 / 11302 (2.3%) | 7689 / 113020 (6.8%) | −95.4 | −93.2 | 0.34 |
| ESR1 SRX371470 | ZR-75-1 Breast | 245 / 11302 (2.2%) | 7366 / 113020 (6.5%) | −95.3 | −93.0 | 0.33 |
| JUNB SRX8488074 | SUM 229PE Breast | 342 / 11302 (3.0%) | 8866 / 113020 (7.8%) | −95.0 | −92.8 | 0.39 |
| JUNB SRX10119383 | MCF 10A Breast | 177 / 11302 (1.6%) | 6219 / 113020 (5.5%) | −95.0 | −92.7 | 0.28 |
| JUNB SRX4192882 | MCF 10A Breast | 206 / 11302 (1.8%) | 6709 / 113020 (5.9%) | −94.9 | −92.6 | 0.31 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 346 / 11302 (3.1%) | 772 / 113020 (0.7%) | −94.6 | −92.4 | 4.48 |
| GATA3 SRX176864 | MCF-7 Breast | 200 / 11302 (1.8%) | 6603 / 113020 (5.8%) | −94.6 | −92.4 | 0.30 |
| VGLL1 SRX24602130 | BT-20 Breast | 275 / 11302 (2.4%) | 7820 / 113020 (6.9%) | −94.6 | −92.3 | 0.35 |
| YAP1 SRX5718140 | 293 Kidney | 455 / 11302 (4.0%) | 10502 / 113020 (9.3%) | −94.4 | −92.1 | 0.43 |
| ESR1 SRX1531791 | MCF-7 Breast | 267 / 11302 (2.4%) | 7673 / 113020 (6.8%) | −94.1 | −91.8 | 0.35 |
| ESR1 SRX20282954 | MCF-7 Breast | 304 / 11302 (2.7%) | 8226 / 113020 (7.3%) | −93.3 | −91.1 | 0.37 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 266 / 11302 (2.4%) | 7623 / 113020 (6.7%) | −93.1 | −90.9 | 0.35 |
| SMARCA4 SRX5212371 | Mel270 Others | 379 / 11302 (3.4%) | 9350 / 113020 (8.3%) | −93.1 | −90.8 | 0.41 |
| ESR1 SRX194572 | MCF-7 Breast | 178 / 11302 (1.6%) | 6176 / 113020 (5.5%) | −93.1 | −90.8 | 0.29 |
| ESR1 SRX371468 | MCF-7 Breast | 180 / 11302 (1.6%) | 6204 / 113020 (5.5%) | −92.8 | −90.6 | 0.29 |
| ESR1 SRX20282939 | MCF-7 Breast | 322 / 11302 (2.8%) | 8482 / 113020 (7.5%) | −92.8 | −90.6 | 0.38 |
| SMARCA4 SRX5212357 | Mel270 Others | 386 / 11302 (3.4%) | 9438 / 113020 (8.4%) | −92.7 | −90.5 | 0.41 |
| GRHL3 SRX2582161 | NHEK Epidermis | 592 / 11302 (5.2%) | 2091 / 113020 (1.9%) | −92.3 | −90.0 | 2.83 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 512 / 11302 (4.5%) | 11226 / 113020 (9.9%) | −92.3 | −90.0 | 0.46 |
| YAP1 SRX10119364 | MCF 10A Breast | 225 / 11302 (2.0%) | 6909 / 113020 (6.1%) | −91.5 | −89.2 | 0.33 |
| FOS SRX3322636 | MCF-7 Breast | 173 / 11302 (1.5%) | 6032 / 113020 (5.3%) | −91.3 | −89.0 | 0.29 |
| ESR1 SRX371471 | ZR-75-1 Breast | 304 / 11302 (2.7%) | 8146 / 113020 (7.2%) | −91.1 | −88.9 | 0.37 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 256 / 11302 (2.3%) | 7381 / 113020 (6.5%) | −90.8 | −88.5 | 0.35 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 1319 / 11302 (11.7%) | 7043 / 113020 (6.2%) | −90.8 | −88.5 | 1.87 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 832 / 11302 (7.4%) | 15433 / 113020 (13.7%) | −90.3 | −88.1 | 0.54 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 358 / 11302 (3.2%) | 8922 / 113020 (7.9%) | −90.0 | −87.8 | 0.40 |
| ZFX SRX7805372 | 293 Kidney | 995 / 11302 (8.8%) | 4734 / 113020 (4.2%) | −90.0 | −87.7 | 2.10 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 251 / 11302 (2.2%) | 7257 / 113020 (6.4%) | −89.4 | −87.2 | 0.35 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 318 / 11302 (2.8%) | 691 / 113020 (0.6%) | −89.2 | −87.0 | 4.60 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 257 / 11302 (2.3%) | 7332 / 113020 (6.5%) | −88.9 | −86.7 | 0.35 |
| NABP2 SRX9523535 | HT-1080 Bone | 881 / 11302 (7.8%) | 3978 / 113020 (3.5%) | −88.8 | −86.6 | 2.21 |
| ESR1 SRX20282972 | MCF-7 Breast | 321 / 11302 (2.8%) | 8312 / 113020 (7.4%) | −88.6 | −86.4 | 0.39 |
| NKX2-1 SRX2164786 | A549 Lung | 447 / 11302 (4.0%) | 10159 / 113020 (9.0%) | −88.5 | −86.3 | 0.44 |
| SMARCA2 SRX8119677 | MeT-5A Others | 443 / 11302 (3.9%) | 10093 / 113020 (8.9%) | −88.3 | −86.1 | 0.44 |
| GATA3 SRX190194 | SK-N-SH Neural | 636 / 11302 (5.6%) | 12758 / 113020 (11.3%) | −88.3 | −86.1 | 0.50 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 468 / 11302 (4.1%) | 10445 / 113020 (9.2%) | −88.2 | −86.1 | 0.45 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 383 / 11302 (3.4%) | 9220 / 113020 (8.2%) | −88.2 | −86.0 | 0.42 |
| TCF12 SRX190356 | SK-N-SH Neural | 722 / 11302 (6.4%) | 13899 / 113020 (12.3%) | −88.1 | −85.9 | 0.52 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 627 / 11302 (5.5%) | 12624 / 113020 (11.2%) | −88.0 | −85.8 | 0.50 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 295 / 11302 (2.6%) | 7890 / 113020 (7.0%) | −87.9 | −85.7 | 0.37 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 647 / 11302 (5.7%) | 12872 / 113020 (11.4%) | −87.4 | −85.3 | 0.50 |
| JUNB SRX10119384 | MCF 10A Breast | 169 / 11302 (1.5%) | 5840 / 113020 (5.2%) | −87.4 | −85.3 | 0.29 |
| STAT3 SRX150479 | MCF 10A Breast | 255 / 11302 (2.3%) | 7251 / 113020 (6.4%) | −87.4 | −85.2 | 0.35 |
| SSRP1 SRX3436566 | HT-1080 Bone | 211 / 11302 (1.9%) | 282 / 113020 (0.2%) | −87.2 | −85.0 | 7.48 |
| ESR1 SRX2897220 | Breast cancer cells Breast | 995 / 11302 (8.8%) | 4800 / 113020 (4.2%) | −87.2 | −85.0 | 2.07 |
| PHF6 SRX11508321 | G-401 Kidney | 979 / 11302 (8.7%) | 4690 / 113020 (4.1%) | −87.0 | −84.8 | 2.09 |
| RELA SRX5938177 | FaDu Others | 255 / 11302 (2.3%) | 7230 / 113020 (6.4%) | −86.9 | −84.7 | 0.35 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 370 / 11302 (3.3%) | 8973 / 113020 (7.9%) | −86.8 | −84.6 | 0.41 |
| ATF3 SRX2207918 | CS1AN Epidermis | 1451 / 11302 (12.8%) | 8157 / 113020 (7.2%) | −86.6 | −84.5 | 1.78 |
| ESR1 SRX4367192 | MCF-7 Breast | 559 / 11302 (4.9%) | 11639 / 113020 (10.3%) | −86.6 | −84.4 | 0.48 |
| FOXA1 SRX1161175 | MCF-7 Breast | 222 / 11302 (2.0%) | 6690 / 113020 (5.9%) | −86.4 | −84.3 | 0.33 |
| ESR1 SRX10365536 | MCF-7 Breast | 156 / 11302 (1.4%) | 5579 / 113020 (4.9%) | −86.4 | −84.2 | 0.28 |
| JUND SRX150408 | HeLa Uterus | 242 / 11302 (2.1%) | 6998 / 113020 (6.2%) | −86.1 | −84.0 | 0.35 |
| CDK9 SRX7366783 | MCF-7 Breast | 151 / 11302 (1.3%) | 112 / 113020 (0.1%) | −85.6 | −83.4 | 13.48 |
| STAT3 SRX150630 | MCF 10A Breast | 257 / 11302 (2.3%) | 7214 / 113020 (6.4%) | −85.6 | −83.4 | 0.36 |
| FOXA1 SRX1161174 | MCF-7 Breast | 301 / 11302 (2.7%) | 7887 / 113020 (7.0%) | −85.4 | −83.2 | 0.38 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 769 / 11302 (6.8%) | 14384 / 113020 (12.7%) | −85.4 | −83.2 | 0.53 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 612 / 11302 (5.4%) | 12301 / 113020 (10.9%) | −85.2 | −83.0 | 0.50 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 259 / 11302 (2.3%) | 7233 / 113020 (6.4%) | −85.2 | −83.0 | 0.36 |
| FOS SRX070879 | HUVEC Cardiovascular | 297 / 11302 (2.6%) | 7803 / 113020 (6.9%) | −84.7 | −82.6 | 0.38 |
| CHD6 SRX17709200 | C4-2 Prostate | 990 / 11302 (8.8%) | 4826 / 113020 (4.3%) | −84.6 | −82.4 | 2.05 |
| FOXA1 SRX371480 | MCF-7 Breast | 201 / 11302 (1.8%) | 6256 / 113020 (5.5%) | −83.9 | −81.8 | 0.32 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 269 / 11302 (2.4%) | 7341 / 113020 (6.5%) | −83.9 | −81.7 | 0.37 |
| GATA3 SRX5057632 | MCF-7 Breast | 196 / 11302 (1.7%) | 6175 / 113020 (5.5%) | −83.9 | −81.7 | 0.32 |
| Epitope tags SRX14024875 | Mesenchymal stem cells Others | 1143 / 11302 (10.1%) | 5938 / 113020 (5.3%) | −83.9 | −81.7 | 1.92 |
| ESR1 SRX371477 | MCF-7 Breast | 149 / 11302 (1.3%) | 5378 / 113020 (4.8%) | −83.8 | −81.7 | 0.28 |
| RBFOX2 SRX4708034 | Hep G2 Liver | 1197 / 11302 (10.6%) | 6336 / 113020 (5.6%) | −83.8 | −81.7 | 1.89 |
| Epitope tags SRX10715360 | HCB1 Blood | 706 / 11302 (6.2%) | 2931 / 113020 (2.6%) | −83.8 | −81.6 | 2.41 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 271 / 11302 (2.4%) | 7358 / 113020 (6.5%) | −83.5 | −81.4 | 0.37 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 541 / 11302 (4.8%) | 11259 / 113020 (10.0%) | −83.4 | −81.3 | 0.48 |
| ZFX SRX7805370 | 293 Kidney | 725 / 11302 (6.4%) | 3059 / 113020 (2.7%) | −83.4 | −81.3 | 2.37 |
| TFEB SRX6743819 | iPS cells Pluripotent stem cell | 930 / 11302 (8.2%) | 4439 / 113020 (3.9%) | −83.2 | −81.1 | 2.10 |
| FOXA1 SRX1787653 | MCF-7 Breast | 240 / 11302 (2.1%) | 6862 / 113020 (6.1%) | −83.2 | −81.1 | 0.35 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 293 / 11302 (2.6%) | 7680 / 113020 (6.8%) | −83.0 | −80.9 | 0.38 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 363 / 11302 (3.2%) | 8718 / 113020 (7.7%) | −82.9 | −80.8 | 0.42 |
| Epitope tags SRX392692 | T3M-1 Cl-10 Others | 124 / 11302 (1.1%) | 60 / 113020 (0.1%) | −82.6 | −80.5 | 20.67 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 255 / 11302 (2.3%) | 7075 / 113020 (6.3%) | −82.5 | −80.4 | 0.36 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 509 / 11302 (4.5%) | 10764 / 113020 (9.5%) | −82.2 | −80.1 | 0.47 |
| Epitope tags SRX15725650 | 293 Kidney | 1035 / 11302 (9.2%) | 5207 / 113020 (4.6%) | −82.0 | −79.9 | 1.99 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 234 / 11302 (2.1%) | 6721 / 113020 (5.9%) | −81.9 | −79.8 | 0.35 |
| 8-Hydroxydeoxyguanosine SRX6895233 | MCF 10A Breast | 536 / 11302 (4.7%) | 1914 / 113020 (1.7%) | −81.9 | −79.8 | 2.80 |
| STAT3 SRX150536 | MCF 10A Breast | 322 / 11302 (2.8%) | 8074 / 113020 (7.1%) | −81.9 | −79.8 | 0.40 |
| CEBPB SRX150632 | HeLa Uterus | 621 / 11302 (5.5%) | 12270 / 113020 (10.9%) | −81.8 | −79.7 | 0.51 |
| CDK9 SRX7366781 | MCF-7 Breast | 142 / 11302 (1.3%) | 102 / 113020 (0.1%) | −81.6 | −79.5 | 13.92 |
| NFYB SRX16608147 | HeLa Uterus | 164 / 11302 (1.5%) | 160 / 113020 (0.1%) | −81.6 | −79.5 | 10.25 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 476 / 11302 (4.2%) | 10281 / 113020 (9.1%) | −81.6 | −79.5 | 0.46 |
| DOT1L SRX10606583 | GIST-T1 Digestive tract | 782 / 11302 (6.9%) | 3476 / 113020 (3.1%) | −81.3 | −79.2 | 2.25 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 207 / 11302 (1.8%) | 6265 / 113020 (5.5%) | −81.2 | −79.1 | 0.33 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 384 / 11302 (3.4%) | 8961 / 113020 (7.9%) | −81.2 | −79.1 | 0.43 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 265 / 11302 (2.3%) | 7179 / 113020 (6.4%) | −81.1 | −79.0 | 0.37 |
| WWTR1 SRX10119367 | MCF 10A Breast | 330 / 11302 (2.9%) | 8156 / 113020 (7.2%) | −80.9 | −78.8 | 0.40 |
| GATA3 SRX5457550 | MCF-7 Breast | 329 / 11302 (2.9%) | 8137 / 113020 (7.2%) | −80.9 | −78.8 | 0.40 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 279 / 11302 (2.5%) | 7384 / 113020 (6.5%) | −80.8 | −78.7 | 0.38 |
| ESR1 SRX20282955 | MCF-7 Breast | 318 / 11302 (2.8%) | 7972 / 113020 (7.1%) | −80.8 | −78.7 | 0.40 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 491 / 11302 (4.3%) | 10455 / 113020 (9.3%) | −80.7 | −78.6 | 0.47 |
| RAC1 SRX10365541 | MCF-7 Breast | 166 / 11302 (1.5%) | 5564 / 113020 (4.9%) | −80.6 | −78.6 | 0.30 |
| SREBF2 SRX5359049 | HCC70 Breast | 744 / 11302 (6.6%) | 3237 / 113020 (2.9%) | −80.6 | −78.5 | 2.30 |
| FOXA1 SRX11222441 | MCF-7 Breast | 232 / 11302 (2.1%) | 6644 / 113020 (5.9%) | −80.6 | −78.5 | 0.35 |
| Epitope tags SRX392691 | T3M-1 Cl-10 Others | 126 / 11302 (1.1%) | 69 / 113020 (0.1%) | −80.5 | −78.4 | 18.26 |
| TEAD1 SRX3401272 | MCF-7 Breast | 223 / 11302 (2.0%) | 6492 / 113020 (5.7%) | −80.4 | −78.3 | 0.34 |
| FOXA1 SRX100454 | T-47D Breast | 385 / 11302 (3.4%) | 8938 / 113020 (7.9%) | −80.3 | −78.2 | 0.43 |
| FOXA1 SRX11222442 | MCF-7 Breast | 202 / 11302 (1.8%) | 6148 / 113020 (5.4%) | −80.2 | −78.2 | 0.33 |
| LARP7 SRX2198835 | HeLa Uterus | 1302 / 11302 (11.5%) | 7226 / 113020 (6.4%) | −80.1 | −78.1 | 1.80 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 240 / 11302 (2.1%) | 6744 / 113020 (6.0%) | −79.9 | −77.9 | 0.36 |
| CXXC1 SRX1424886 | SEM Blood | 907 / 11302 (8.0%) | 4361 / 113020 (3.9%) | −79.7 | −77.6 | 2.08 |
| ESR1 SRX10365535 | MCF-7 Breast | 250 / 11302 (2.2%) | 6886 / 113020 (6.1%) | −79.5 | −77.5 | 0.36 |
| JUNB SRX10119385 | MCF 10A Breast | 135 / 11302 (1.2%) | 4990 / 113020 (4.4%) | −79.5 | −77.5 | 0.27 |
| PRRX1 SRX15235713 | Hs 578T Breast | 351 / 11302 (3.1%) | 8407 / 113020 (7.4%) | −79.4 | −77.4 | 0.42 |
| JADE3 DRX300415 | 293 Kidney | 935 / 11302 (8.3%) | 4567 / 113020 (4.0%) | −79.3 | −77.3 | 2.05 |
| CHD6 SRX17709201 | C4-2 Prostate | 948 / 11302 (8.4%) | 4661 / 113020 (4.1%) | −79.1 | −77.0 | 2.03 |
| PHF6 SRX11508322 | G-401 Kidney | 563 / 11302 (5.0%) | 2121 / 113020 (1.9%) | −79.0 | −77.0 | 2.65 |
| ESR1 SRX20282940 | MCF-7 Breast | 329 / 11302 (2.9%) | 8065 / 113020 (7.1%) | −79.0 | −76.9 | 0.41 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 494 / 11302 (4.4%) | 10417 / 113020 (9.2%) | −78.9 | −76.8 | 0.47 |
| FOXA1 SRX1447317 | MCF-7 Breast | 198 / 11302 (1.8%) | 6029 / 113020 (5.3%) | −78.7 | −76.6 | 0.33 |
| ESR1 SRX20282973 | MCF-7 Breast | 365 / 11302 (3.2%) | 8577 / 113020 (7.6%) | −78.5 | −76.5 | 0.43 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 217 / 11302 (1.9%) | 6321 / 113020 (5.6%) | −78.3 | −76.3 | 0.34 |
| AR SRX1067067 | LHSAR Prostate | 492 / 11302 (4.4%) | 10359 / 113020 (9.2%) | −78.1 | −76.1 | 0.47 |
| FOSL2 SRX190296 | SK-N-SH Neural | 394 / 11302 (3.5%) | 8974 / 113020 (7.9%) | −78.0 | −75.9 | 0.44 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 672 / 11302 (5.9%) | 2821 / 113020 (2.5%) | −78.0 | −75.9 | 2.38 |
| Epitope tags SRX10549778 | K-562 Blood | 687 / 11302 (6.1%) | 2919 / 113020 (2.6%) | −77.9 | −75.9 | 2.35 |
| AR SRX9469988 | LAPC-4 Prostate | 394 / 11302 (3.5%) | 8968 / 113020 (7.9%) | −77.9 | −75.8 | 0.44 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 151 / 11302 (1.3%) | 5214 / 113020 (4.6%) | −77.8 | −75.8 | 0.29 |
| JUND SRX190357 | SK-N-SH Neural | 374 / 11302 (3.3%) | 8677 / 113020 (7.7%) | −77.8 | −75.8 | 0.43 |
| MCM3 SRX9107920 | hTERT RPE-1 Neural | 575 / 11302 (5.1%) | 2214 / 113020 (2.0%) | −77.8 | −75.8 | 2.60 |
| CHD1 SRX116417 | K-562 Blood | 420 / 11302 (3.7%) | 1315 / 113020 (1.2%) | −77.8 | −75.7 | 3.19 |
| ESR1 SRX2881000 | MCF-7 Breast | 272 / 11302 (2.4%) | 7159 / 113020 (6.3%) | −77.7 | −75.7 | 0.38 |
| YAP1 SRX10119388 | MDA-MB-231 Breast | 208 / 11302 (1.8%) | 6152 / 113020 (5.4%) | −77.6 | −75.6 | 0.34 |
| CBX3 SRX055348 | HCT 116 Digestive tract | 226 / 11302 (2.0%) | 391 / 113020 (0.3%) | −77.5 | −75.5 | 5.78 |
| Epitope tags SRX2867680 | 293 Kidney | 1277 / 11302 (11.3%) | 7118 / 113020 (6.3%) | −77.5 | −75.5 | 1.79 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 315 / 11302 (2.8%) | 7801 / 113020 (6.9%) | −77.5 | −75.5 | 0.40 |
| RAC1 SRX10365543 | MCF-7 Breast | 171 / 11302 (1.5%) | 5543 / 113020 (4.9%) | −77.4 | −75.4 | 0.31 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 307 / 11302 (2.7%) | 7675 / 113020 (6.8%) | −77.4 | −75.3 | 0.40 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 455 / 11302 (4.0%) | 9805 / 113020 (8.7%) | −77.2 | −75.2 | 0.46 |
| Epitope tags SRX15725652 | 293 Kidney | 1140 / 11302 (10.1%) | 6101 / 113020 (5.4%) | −77.2 | −75.2 | 1.87 |
| FOXA1 SRX3923514 | MCF-7 Breast | 313 / 11302 (2.8%) | 7746 / 113020 (6.9%) | −76.8 | −74.8 | 0.40 |
| ESR1 SRX330070 | MCF-7 Breast | 163 / 11302 (1.4%) | 5387 / 113020 (4.8%) | −76.8 | −74.8 | 0.30 |
| TET2 SRX1427029 | 293 Kidney | 793 / 11302 (7.0%) | 3644 / 113020 (3.2%) | −76.8 | −74.8 | 2.18 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 643 / 11302 (5.7%) | 12336 / 113020 (10.9%) | −76.7 | −74.7 | 0.52 |
| ARID5B SRX3230377 | Hep G2 Liver | 706 / 11302 (6.2%) | 13160 / 113020 (11.6%) | −76.7 | −74.7 | 0.54 |
| SMARCA4 SRX8588623 | Pulmonary artery endothelial cells Cardiovascular | 411 / 11302 (3.6%) | 9162 / 113020 (8.1%) | −76.6 | −74.6 | 0.45 |
| ESR1 SRX330069 | MCF-7 Breast | 193 / 11302 (1.7%) | 5876 / 113020 (5.2%) | −76.6 | −74.6 | 0.33 |
| CHD1 SRX116454 | hESC H1 Pluripotent stem cell | 507 / 11302 (4.5%) | 1828 / 113020 (1.6%) | −76.4 | −74.4 | 2.77 |
| ESR1 SRX330067 | MCF-7 Breast | 279 / 11302 (2.5%) | 7216 / 113020 (6.4%) | −76.4 | −74.4 | 0.39 |
| NR2F2 SRX190293 | MCF-7 Breast | 321 / 11302 (2.8%) | 7847 / 113020 (6.9%) | −76.4 | −74.4 | 0.41 |
| KAT6A DRX366108 | 293 Kidney | 1052 / 11302 (9.3%) | 5479 / 113020 (4.8%) | −76.4 | −74.4 | 1.92 |
| 8-Hydroxydeoxyguanosine SRX6895232 | MCF 10A Breast | 552 / 11302 (4.9%) | 2099 / 113020 (1.9%) | −76.3 | −74.3 | 2.63 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 233 / 11302 (2.1%) | 6501 / 113020 (5.8%) | −76.3 | −74.3 | 0.36 |
| JUN SRX2355072 | HAEC Cardiovascular | 382 / 11302 (3.4%) | 8729 / 113020 (7.7%) | −76.2 | −74.2 | 0.44 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 863 / 11302 (7.6%) | 4143 / 113020 (3.7%) | −76.0 | −74.0 | 2.08 |
| HEXIM1 SRX1177905 | HCT 116 Digestive tract | 1132 / 11302 (10.0%) | 6076 / 113020 (5.4%) | −75.9 | −73.9 | 1.86 |
| ESR1 SRX10365532 | MCF-7 Breast | 177 / 11302 (1.6%) | 5591 / 113020 (4.9%) | −75.9 | −73.9 | 0.32 |
| ARID1A SRX5089376 | MCF-7 Breast | 272 / 11302 (2.4%) | 7095 / 113020 (6.3%) | −75.9 | −73.9 | 0.38 |
| JUN SRX6582172 | Fibroblasts Others | 393 / 11302 (3.5%) | 8870 / 113020 (7.8%) | −75.8 | −73.8 | 0.44 |
| DAXX SRX1021630 | PC-3 Prostate | 302 / 11302 (2.7%) | 7537 / 113020 (6.7%) | −75.7 | −73.7 | 0.40 |
| WWTR1 SRX10119378 | MCF 10A Breast | 323 / 11302 (2.9%) | 7851 / 113020 (6.9%) | −75.7 | −73.7 | 0.41 |
| ESR1 SRX20282946 | MCF-7 Breast | 193 / 11302 (1.7%) | 5844 / 113020 (5.2%) | −75.6 | −73.6 | 0.33 |
| KMT2A SRX2281249 | SEM Blood | 1190 / 11302 (10.5%) | 6520 / 113020 (5.8%) | −75.5 | −73.5 | 1.83 |
| ESR1 SRX2881002 | MCF-7 Breast | 297 / 11302 (2.6%) | 7453 / 113020 (6.6%) | −75.5 | −73.5 | 0.40 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 505 / 11302 (4.5%) | 10412 / 113020 (9.2%) | −75.2 | −73.2 | 0.49 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 264 / 11302 (2.3%) | 6941 / 113020 (6.1%) | −75.1 | −73.1 | 0.38 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 513 / 11302 (4.5%) | 10508 / 113020 (9.3%) | −75.0 | −73.0 | 0.49 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 283 / 11302 (2.5%) | 7221 / 113020 (6.4%) | −74.9 | −72.9 | 0.39 |
| NR3C1 SRX9298951 | Lung cancer cell line Lung | 192 / 11302 (1.7%) | 5796 / 113020 (5.1%) | −74.9 | −72.9 | 0.33 |
| KAT7 DRX234808 | 293 Kidney | 465 / 11302 (4.1%) | 1605 / 113020 (1.4%) | −74.8 | −72.8 | 2.90 |
| MAML1 SRX8970969 | Squamous cell carcinoma Others | 297 / 11302 (2.6%) | 7427 / 113020 (6.6%) | −74.7 | −72.7 | 0.40 |
| ESR1 SRX371475 | BT-474 Breast | 166 / 11302 (1.5%) | 5364 / 113020 (4.7%) | −74.7 | −72.7 | 0.31 |
| Epitope tags SRX4192708 | MDA-MB-231 Breast | 629 / 11302 (5.6%) | 2607 / 113020 (2.3%) | −74.6 | −72.6 | 2.41 |
| TEAD4 SRX10640861 | SK-MEL-147 Epidermis | 325 / 11302 (2.9%) | 7839 / 113020 (6.9%) | −74.6 | −72.6 | 0.41 |
| ESR1 SRX3110725 | MCF-7 Breast | 278 / 11302 (2.5%) | 7133 / 113020 (6.3%) | −74.6 | −72.6 | 0.39 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 230 / 11302 (2.0%) | 6393 / 113020 (5.7%) | −74.6 | −72.6 | 0.36 |
| FOS SRX3322637 | MCF-7 Breast | 166 / 11302 (1.5%) | 5358 / 113020 (4.7%) | −74.6 | −72.6 | 0.31 |
| RBM22 SRX4708083 | K-562 Blood | 569 / 11302 (5.0%) | 2231 / 113020 (2.0%) | −74.5 | −72.6 | 2.55 |
| SMARCA4 SRX5982340 | A549 Lung | 130 / 11302 (1.2%) | 4740 / 113020 (4.2%) | −74.5 | −72.5 | 0.27 |
| DOT1L SRX10606582 | GIST-T1 Digestive tract | 1031 / 11302 (9.1%) | 5375 / 113020 (4.8%) | −74.5 | −72.5 | 1.92 |
| EP300 SRX150579 | HeLa Uterus | 206 / 11302 (1.8%) | 6011 / 113020 (5.3%) | −74.4 | −72.4 | 0.34 |
| ESR1 SRX2943591 | MCF-7 Breast | 226 / 11302 (2.0%) | 6324 / 113020 (5.6%) | −74.3 | −72.4 | 0.36 |
| AR SRX9109110 | MDA-MB-453 Breast | 544 / 11302 (4.8%) | 10901 / 113020 (9.6%) | −74.3 | −72.3 | 0.50 |
| FOXA2 SRX100448 | Hep G2 Liver | 336 / 11302 (3.0%) | 7979 / 113020 (7.1%) | −74.1 | −72.1 | 0.42 |
| DNA-RNA hybrid SRX20083261 | SH-SY5Y Neural | 346 / 11302 (3.1%) | 967 / 113020 (0.9%) | −74.1 | −72.1 | 3.58 |
| FOXA1 SRX3931043 | MCF-7 Breast | 318 / 11302 (2.8%) | 7709 / 113020 (6.8%) | −74.0 | −72.0 | 0.41 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 160 / 11302 (1.4%) | 5236 / 113020 (4.6%) | −73.9 | −71.9 | 0.31 |
| FOXA1 SRX11222437 | MCF-7 Breast | 233 / 11302 (2.1%) | 6412 / 113020 (5.7%) | −73.8 | −71.8 | 0.36 |
| JUN SRX6582171 | GM07492 Others | 564 / 11302 (5.0%) | 11143 / 113020 (9.9%) | −73.7 | −71.7 | 0.51 |
| WAS SRX5371250 | GM11518 Blood | 677 / 11302 (6.0%) | 2937 / 113020 (2.6%) | −73.7 | −71.7 | 2.31 |
| FOXA1 SRX028634 | MCF-7 Breast | 161 / 11302 (1.4%) | 5242 / 113020 (4.6%) | −73.6 | −71.6 | 0.31 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 810 / 11302 (7.2%) | 3833 / 113020 (3.4%) | −73.6 | −71.6 | 2.11 |
| EP300 SRX2194266 | SUM 159PT Breast | 507 / 11302 (4.5%) | 10362 / 113020 (9.2%) | −73.5 | −71.6 | 0.49 |
| ARID1A SRX5089379 | MCF-7 Breast | 312 / 11302 (2.8%) | 7601 / 113020 (6.7%) | −73.5 | −71.5 | 0.41 |
| Crotonyllysine SRX19488269 | GSC23 Neural | 737 / 11302 (6.5%) | 3336 / 113020 (3.0%) | −73.5 | −71.5 | 2.21 |
| ESR1 SRX4451213 | MCF-7 Breast | 314 / 11302 (2.8%) | 7629 / 113020 (6.8%) | −73.4 | −71.5 | 0.41 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 284 / 11302 (2.5%) | 7178 / 113020 (6.4%) | −73.3 | −71.3 | 0.40 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 234 / 11302 (2.1%) | 6404 / 113020 (5.7%) | −73.2 | −71.2 | 0.37 |
| FOXL2 SRX6957431 | KGN Gonad | 665 / 11302 (5.9%) | 12455 / 113020 (11.0%) | −73.1 | −71.2 | 0.53 |
| EP300 SRX2671813 | Fibroblasts Others | 262 / 11302 (2.3%) | 6832 / 113020 (6.0%) | −73.0 | −71.1 | 0.38 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 820 / 11302 (7.3%) | 14446 / 113020 (12.8%) | −73.0 | −71.1 | 0.57 |
| LEO1 SRX15147190 | DLD-1 Digestive tract | 523 / 11302 (4.6%) | 1975 / 113020 (1.7%) | −73.0 | −71.1 | 2.65 |
| CHD1 SRX186771 | K-562 Blood | 433 / 11302 (3.8%) | 1450 / 113020 (1.3%) | −72.9 | −71.0 | 2.99 |
| INTS3 SRX3640569 | HeLa Uterus | 774 / 11302 (6.8%) | 3601 / 113020 (3.2%) | −72.9 | −71.0 | 2.15 |
| AR SRX9109113 | MDA-MB-453 Breast | 559 / 11302 (4.9%) | 11036 / 113020 (9.8%) | −72.8 | −70.9 | 0.51 |
| FOXA2 SRX3230382 | Hep G2 Liver | 412 / 11302 (3.6%) | 9014 / 113020 (8.0%) | −72.8 | −70.8 | 0.46 |
| FOXA1 SRX1787655 | MCF-7 Breast | 163 / 11302 (1.4%) | 5248 / 113020 (4.6%) | −72.7 | −70.8 | 0.31 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 263 / 11302 (2.3%) | 6836 / 113020 (6.0%) | −72.7 | −70.7 | 0.38 |
| FOXA1 SRX3931054 | MCF-7 Breast | 299 / 11302 (2.6%) | 7376 / 113020 (6.5%) | −72.7 | −70.7 | 0.41 |
| FOXA1 SRX1161203 | T-47D Breast | 230 / 11302 (2.0%) | 6322 / 113020 (5.6%) | −72.6 | −70.7 | 0.36 |
| SS18 SRX10640841 | SK-MEL-147 Epidermis | 432 / 11302 (3.8%) | 9286 / 113020 (8.2%) | −72.5 | −70.6 | 0.47 |
| 8-Hydroxydeoxyguanosine SRX6895234 | MCF 10A Breast | 504 / 11302 (4.5%) | 1869 / 113020 (1.7%) | −72.5 | −70.6 | 2.70 |
| ESR1 SRX8537722 | MCF-7 Breast | 296 / 11302 (2.6%) | 7320 / 113020 (6.5%) | −72.4 | −70.4 | 0.40 |
| KDM1A SRX10637290 | MDA-MB-231 Breast | 383 / 11302 (3.4%) | 8584 / 113020 (7.6%) | −72.2 | −70.3 | 0.45 |
| SS18 SRX3468047 | Fibroblasts Others | 725 / 11302 (6.4%) | 13184 / 113020 (11.7%) | −72.0 | −70.1 | 0.55 |
| FOXA1 SRX9550926 | Prostate cancer Prostate | 365 / 11302 (3.2%) | 8311 / 113020 (7.4%) | −72.0 | −70.0 | 0.44 |
| ESR1 SRX1012632 | MCF-7 Breast | 164 / 11302 (1.5%) | 5234 / 113020 (4.6%) | −71.9 | −69.9 | 0.31 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 207 / 11302 (1.8%) | 5929 / 113020 (5.2%) | −71.8 | −69.9 | 0.35 |
| MYC SRX150570 | MCF 10A Breast | 209 / 11302 (1.8%) | 5963 / 113020 (5.3%) | −71.8 | −69.8 | 0.35 |
| ESR1 SRX20282953 | MCF-7 Breast | 269 / 11302 (2.4%) | 6890 / 113020 (6.1%) | −71.7 | −69.8 | 0.39 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 337 / 11302 (3.0%) | 7897 / 113020 (7.0%) | −71.7 | −69.8 | 0.43 |
| ESR1 SRX5323873 | MCF-7 Breast | 381 / 11302 (3.4%) | 8534 / 113020 (7.6%) | −71.7 | −69.8 | 0.45 |
| KAT6A DRX366109 | 293 Kidney | 1250 / 11302 (11.1%) | 7096 / 113020 (6.3%) | −71.6 | −69.7 | 1.76 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 292 / 11302 (2.6%) | 7231 / 113020 (6.4%) | −71.5 | −69.6 | 0.40 |
| ESR1 SRX2513521 | MCF-7 Breast | 156 / 11302 (1.4%) | 5088 / 113020 (4.5%) | −71.5 | −69.6 | 0.31 |
| FOXA1 SRX5203303 | MCF-7 Breast | 116 / 11302 (1.0%) | 4394 / 113020 (3.9%) | −71.5 | −69.6 | 0.26 |
| TAL1 SRX393516 | Primary endothelial cells Cardiovascular | 365 / 11302 (3.2%) | 8294 / 113020 (7.3%) | −71.5 | −69.6 | 0.44 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 266 / 11302 (2.4%) | 6823 / 113020 (6.0%) | −71.2 | −69.3 | 0.39 |
| EP300 SRX2194265 | SUM 159PT Breast | 463 / 11302 (4.1%) | 9656 / 113020 (8.5%) | −71.1 | −69.2 | 0.48 |
| FOS SRX150664 | HUVEC Cardiovascular | 404 / 11302 (3.6%) | 8833 / 113020 (7.8%) | −71.1 | −69.2 | 0.46 |
| PGR SRX1012655 | MCF-7 Breast | 211 / 11302 (1.9%) | 5969 / 113020 (5.3%) | −71.1 | −69.2 | 0.35 |
| Epitope tags SRX8030771 | 293 Kidney | 987 / 11302 (8.7%) | 5147 / 113020 (4.6%) | −71.1 | −69.2 | 1.92 |
| ETS1 SRX3033231 | HEYA8 Gonad | 175 / 11302 (1.5%) | 241 / 113020 (0.2%) | −71.0 | −69.1 | 7.26 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 308 / 11302 (2.7%) | 7444 / 113020 (6.6%) | −71.0 | −69.1 | 0.41 |
| FOXA1 SRX3923517 | MCF-7 Breast | 234 / 11302 (2.1%) | 6326 / 113020 (5.6%) | −71.0 | −69.1 | 0.37 |
| FOXA1 SRX028635 | MCF-7 Breast | 168 / 11302 (1.5%) | 5259 / 113020 (4.7%) | −70.7 | −68.8 | 0.32 |
| ESR1 SRX20282938 | MCF-7 Breast | 266 / 11302 (2.4%) | 6808 / 113020 (6.0%) | −70.7 | −68.8 | 0.39 |
| NANOG SRX10448024 | hESC H1 Pluripotent stem cell | 996 / 11302 (8.8%) | 16521 / 113020 (14.6%) | −70.7 | −68.8 | 0.60 |
| 8-Hydroxydeoxyguanosine SRX2935292 | MCF 10A Breast | 995 / 11302 (8.8%) | 5221 / 113020 (4.6%) | −70.5 | −68.6 | 1.91 |
| DMC1 SRX663450 | Testis Gonad | 354 / 11302 (3.1%) | 1048 / 113020 (0.9%) | −70.5 | −68.6 | 3.38 |
| FOSL2 SRX190204 | A549 Lung | 310 / 11302 (2.7%) | 7453 / 113020 (6.6%) | −70.4 | −68.5 | 0.42 |
| AFF1 SRX2281250 | SEM Blood | 577 / 11302 (5.1%) | 2359 / 113020 (2.1%) | −70.2 | −68.3 | 2.45 |
| FOXA1 SRX3931055 | MCF-7 Breast | 276 / 11302 (2.4%) | 6931 / 113020 (6.1%) | −70.1 | −68.2 | 0.40 |
| RNF2 SRX18954719 | SCC-25 Others | 416 / 11302 (3.7%) | 8958 / 113020 (7.9%) | −70.0 | −68.1 | 0.46 |
| ESR1 SRX371474 | BT-474 Breast | 158 / 11302 (1.4%) | 5071 / 113020 (4.5%) | −70.0 | −68.1 | 0.31 |
| FOXA1 SRX1787651 | MCF-7 Breast | 190 / 11302 (1.7%) | 5592 / 113020 (4.9%) | −69.9 | −68.0 | 0.34 |
| MethylCap SRX014767 | NB-4 Blood | 1036 / 11302 (9.2%) | 5538 / 113020 (4.9%) | −69.9 | −68.0 | 1.87 |
| FOSL1 SRX190212 | HCT 116 Digestive tract | 362 / 11302 (3.2%) | 8185 / 113020 (7.2%) | −69.9 | −68.0 | 0.44 |
| FOXA1 SRX1787652 | MCF-7 Breast | 203 / 11302 (1.8%) | 5799 / 113020 (5.1%) | −69.8 | −67.9 | 0.35 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 300 / 11302 (2.7%) | 7268 / 113020 (6.4%) | −69.5 | −67.6 | 0.41 |
| SMARCA2 SRX5982361 | A549 Lung | 114 / 11302 (1.0%) | 4296 / 113020 (3.8%) | −69.5 | −67.6 | 0.27 |
| ESR1 SRX20282971 | MCF-7 Breast | 324 / 11302 (2.9%) | 7614 / 113020 (6.7%) | −69.4 | −67.5 | 0.43 |
| ESR1 SRX5323871 | MCF-7 Breast | 348 / 11302 (3.1%) | 7965 / 113020 (7.0%) | −69.4 | −67.5 | 0.44 |
| ESR1 SRX2943589 | MCF-7 Breast | 174 / 11302 (1.5%) | 5313 / 113020 (4.7%) | −69.4 | −67.5 | 0.33 |
| EP300 SRX1012648 | MCF-7 Breast | 161 / 11302 (1.4%) | 5099 / 113020 (4.5%) | −69.4 | −67.5 | 0.32 |
| TFAP2C SRX018833 | MCF-7 Breast | 282 / 11302 (2.5%) | 6991 / 113020 (6.2%) | −69.3 | −67.4 | 0.40 |
| EP300 SRX176885 | MCF-7 Breast | 174 / 11302 (1.5%) | 5307 / 113020 (4.7%) | −69.2 | −67.3 | 0.33 |
| CEBPA SRX2630241 | Hep G2 Liver | 382 / 11302 (3.4%) | 8441 / 113020 (7.5%) | −69.2 | −67.3 | 0.45 |
| MethylCap SRX014766 | NB-4 Blood | 935 / 11302 (8.3%) | 4826 / 113020 (4.3%) | −69.1 | −67.2 | 1.94 |
| VGLL1 SRX18013277 | FULVR Breast | 146 / 11302 (1.3%) | 4836 / 113020 (4.3%) | −69.1 | −67.2 | 0.30 |
| ESR1 SRX1531796 | MCF-7 Breast | 184 / 11302 (1.6%) | 5467 / 113020 (4.8%) | −69.1 | −67.2 | 0.34 |
| GFP SRX6949256 | HeLa Uterus | 350 / 11302 (3.1%) | 7977 / 113020 (7.1%) | −69.0 | −67.1 | 0.44 |
| TEAD1 SRX1011298 | HuCCT1 Liver | 139 / 11302 (1.2%) | 4714 / 113020 (4.2%) | −68.9 | −67.0 | 0.29 |
| GTF3C1 SRX4636577 | 293 Kidney | 794 / 11302 (7.0%) | 3833 / 113020 (3.4%) | −68.9 | −67.0 | 2.07 |
| YAP1 SRX10119387 | MDA-MB-231 Breast | 239 / 11302 (2.1%) | 6321 / 113020 (5.6%) | −68.8 | −66.9 | 0.38 |
| HDAC1 SRX20517420 | Keratinocytes Epidermis | 1007 / 11302 (8.9%) | 5362 / 113020 (4.7%) | −68.7 | −66.8 | 1.88 |
| Epitope tags SRX392690 | T3M-1 Cl-10 Others | 102 / 11302 (0.9%) | 48 / 113020 (0.0%) | −68.7 | −66.8 | 21.25 |
| CDK9 SRX20230567 | Ishikawa Uterus | 1053 / 11302 (9.3%) | 5705 / 113020 (5.0%) | −68.6 | −66.7 | 1.85 |
| CBFB SRX265218 | ME-1 Blood | 883 / 11302 (7.8%) | 4466 / 113020 (4.0%) | −68.6 | −66.7 | 1.98 |
| NUP98 SRX20440536 | Keratinocytes Epidermis | 283 / 11302 (2.5%) | 710 / 113020 (0.6%) | −68.6 | −66.7 | 3.99 |
| FOSL1 SRX2585779 | MDA-MB-231 Breast | 166 / 11302 (1.5%) | 5153 / 113020 (4.6%) | −68.6 | −66.7 | 0.32 |
| SMARCA4 SRX5982364 | A549 Lung | 113 / 11302 (1.0%) | 4246 / 113020 (3.8%) | −68.5 | −66.7 | 0.27 |
| KMT2A SRX2323895 | 293 Kidney | 231 / 11302 (2.0%) | 474 / 113020 (0.4%) | −68.5 | −66.6 | 4.87 |
| SMARCA4 SRX5982341 | A549 Lung | 109 / 11302 (1.0%) | 4174 / 113020 (3.7%) | −68.5 | −66.6 | 0.26 |
| STAT3 SRX2020842 | HCC70 Breast | 533 / 11302 (4.7%) | 10491 / 113020 (9.3%) | −68.5 | −66.6 | 0.51 |
| JUND SRX092301 | K-562 Blood | 412 / 11302 (3.6%) | 8829 / 113020 (7.8%) | −68.4 | −66.6 | 0.47 |
| ESR1 SRX10365558 | MCF-7 Breast | 228 / 11302 (2.0%) | 6137 / 113020 (5.4%) | −68.4 | −66.5 | 0.37 |
| FOXA1 SRX3923518 | MCF-7 Breast | 231 / 11302 (2.0%) | 6178 / 113020 (5.5%) | −68.3 | −66.4 | 0.37 |
| TLE3 SRX4815192 | MCF-7 Breast | 302 / 11302 (2.7%) | 7245 / 113020 (6.4%) | −68.2 | −66.3 | 0.42 |
| FOXA1 SRX3923516 | MCF-7 Breast | 241 / 11302 (2.1%) | 6327 / 113020 (5.6%) | −68.1 | −66.2 | 0.38 |
| ESR1 SRX1469949 | MCF-7 Breast | 197 / 11302 (1.7%) | 5637 / 113020 (5.0%) | −68.0 | −66.2 | 0.35 |
| ARID1A SRX5679788 | 12Z Others | 143 / 11302 (1.3%) | 4747 / 113020 (4.2%) | −67.9 | −66.1 | 0.30 |
| PBX3 SRX190343 | SK-N-SH Neural | 622 / 11302 (5.5%) | 11645 / 113020 (10.3%) | −67.9 | −66.1 | 0.53 |
| ESR1 SRX2513517 | MCF-7 Breast | 231 / 11302 (2.0%) | 6163 / 113020 (5.5%) | −67.9 | −66.0 | 0.37 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 278 / 11302 (2.5%) | 6876 / 113020 (6.1%) | −67.9 | −66.0 | 0.40 |
| FOXA1 SRX100506 | Hep G2 Liver | 413 / 11302 (3.7%) | 8816 / 113020 (7.8%) | −67.8 | −65.9 | 0.47 |
| AR SRX1067066 | LHSAR Prostate | 635 / 11302 (5.6%) | 11806 / 113020 (10.4%) | −67.7 | −65.9 | 0.54 |
| FOXA1 SRX5323843 | MCF-7 Breast | 178 / 11302 (1.6%) | 5319 / 113020 (4.7%) | −67.7 | −65.8 | 0.33 |
| FOSL2 SRX5054308 | Neural progenitor cells Neural | 243 / 11302 (2.2%) | 6345 / 113020 (5.6%) | −67.7 | −65.8 | 0.38 |
| FOXA1 SRX13814018 | 5637 Others | 205 / 11302 (1.8%) | 5748 / 113020 (5.1%) | −67.6 | −65.8 | 0.36 |
| TFAP2C SRX128099 | MCF-7 Breast | 286 / 11302 (2.5%) | 6982 / 113020 (6.2%) | −67.5 | −65.7 | 0.41 |
| TEAD4 SRX10640862 | SK-MEL-147 Epidermis | 473 / 11302 (4.2%) | 9637 / 113020 (8.5%) | −67.5 | −65.7 | 0.49 |
| TEAD3 SRX2636153 | Hep G2 Liver | 716 / 11302 (6.3%) | 12839 / 113020 (11.4%) | −67.4 | −65.6 | 0.56 |
| ARID1A SRX5089385 | MCF-7 Breast | 252 / 11302 (2.2%) | 6471 / 113020 (5.7%) | −67.4 | −65.6 | 0.39 |
| FOXA1 SRX3923519 | MCF-7 Breast | 211 / 11302 (1.9%) | 5833 / 113020 (5.2%) | −67.3 | −65.5 | 0.36 |
| JUN SRX9350646 | Melanoma cell line Epidermis | 413 / 11302 (3.7%) | 8798 / 113020 (7.8%) | −67.3 | −65.5 | 0.47 |
| BRD2 SRX8090642 | Synoviocytes Others | 644 / 11302 (5.7%) | 2849 / 113020 (2.5%) | −67.3 | −65.5 | 2.26 |
| RBFOX2 SRX3323050 | Hep G2 Liver | 923 / 11302 (8.2%) | 4787 / 113020 (4.2%) | −67.3 | −65.4 | 1.93 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 268 / 11302 (2.4%) | 6702 / 113020 (5.9%) | −67.2 | −65.4 | 0.40 |
| NANOG SRX5286326 | hESC WIBR2 Pluripotent stem cell | 272 / 11302 (2.4%) | 6756 / 113020 (6.0%) | −67.1 | −65.2 | 0.40 |
| EP300 SRX176883 | MCF-7 Breast | 162 / 11302 (1.4%) | 5033 / 113020 (4.5%) | −66.9 | −65.0 | 0.32 |
| DNA-RNA hybrid SRX14756935 | MDA-MB-436 Breast | 326 / 11302 (2.9%) | 945 / 113020 (0.8%) | −66.7 | −64.9 | 3.45 |
| NKX2-1 SRX366169 | NCI-H441 Lung | 381 / 11302 (3.4%) | 8322 / 113020 (7.4%) | −66.7 | −64.9 | 0.46 |
| FOS SRX7760064 | CFPAC-1 Pancreas | 265 / 11302 (2.3%) | 6640 / 113020 (5.9%) | −66.7 | −64.9 | 0.40 |
| SMAD3 SRX11483609 | Keratinocytes Epidermis | 445 / 11302 (3.9%) | 9212 / 113020 (8.2%) | −66.7 | −64.8 | 0.48 |
| JUND SRX150648 | K-562 Blood | 417 / 11302 (3.7%) | 8826 / 113020 (7.8%) | −66.7 | −64.8 | 0.47 |
| ESR1 SRX1469951 | MCF-7 Breast | 181 / 11302 (1.6%) | 5330 / 113020 (4.7%) | −66.6 | −64.8 | 0.34 |
| MED1 SRX4937340 | HCT 116 Digestive tract | 951 / 11302 (8.4%) | 5015 / 113020 (4.4%) | −66.4 | −64.6 | 1.90 |
| MED1 SRX4937336 | HCT 116 Digestive tract | 939 / 11302 (8.3%) | 4931 / 113020 (4.4%) | −66.4 | −64.5 | 1.90 |
| CDK9 SRX20230574 | Ishikawa Uterus | 891 / 11302 (7.9%) | 4587 / 113020 (4.1%) | −66.2 | −64.4 | 1.94 |
| Epitope tags SRX15939724 | RD Muscle | 286 / 11302 (2.5%) | 6930 / 113020 (6.1%) | −66.2 | −64.4 | 0.41 |
| ZEB1 SRX13298925 | MCF-7 Breast | 209 / 11302 (1.8%) | 5761 / 113020 (5.1%) | −66.2 | −64.3 | 0.36 |
| SMARCA4 SRX027488 | hESC H9 Pluripotent stem cell | 100 / 11302 (0.9%) | 3937 / 113020 (3.5%) | −66.2 | −64.3 | 0.25 |
| ESR1 SRX330068 | MCF-7 Breast | 168 / 11302 (1.5%) | 5102 / 113020 (4.5%) | −66.1 | −64.3 | 0.33 |
| NCOA3 SRX4663589 | MCF-7 Breast | 103 / 11302 (0.9%) | 3989 / 113020 (3.5%) | −66.1 | −64.3 | 0.26 |
| ESR1 SRX4451212 | MCF-7 Breast | 312 / 11302 (2.8%) | 7312 / 113020 (6.5%) | −66.1 | −64.3 | 0.43 |
| ESR1 SRX1012629 | MCF-7 Breast | 218 / 11302 (1.9%) | 5894 / 113020 (5.2%) | −66.1 | −64.2 | 0.37 |
| ERG SRX063918 | MCF-7 Breast | 883 / 11302 (7.8%) | 4535 / 113020 (4.0%) | −66.0 | −64.2 | 1.95 |
| Epitope tags SRX15426925 | Keratinocytes Epidermis | 323 / 11302 (2.9%) | 940 / 113020 (0.8%) | −65.8 | −64.0 | 3.44 |
| BMI1 SRX8726297 | Tumor Others | 926 / 11302 (8.2%) | 4851 / 113020 (4.3%) | −65.8 | −63.9 | 1.91 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 741 / 11302 (6.6%) | 13075 / 113020 (11.6%) | −65.7 | −63.9 | 0.57 |
| ZNF711 SRX7805362 | 293 Kidney | 863 / 11302 (7.6%) | 4398 / 113020 (3.9%) | −65.7 | −63.9 | 1.96 |
| ZNF711 SRX7805363 | 293 Kidney | 907 / 11302 (8.0%) | 4717 / 113020 (4.2%) | −65.7 | −63.8 | 1.92 |
| MYOCD SRX5598318 | A549 Lung | 1012 / 11302 (9.0%) | 5487 / 113020 (4.9%) | −65.7 | −63.8 | 1.84 |
| HMG20A SRX2630163 | Hep G2 Liver | 196 / 11302 (1.7%) | 5532 / 113020 (4.9%) | −65.6 | −63.8 | 0.35 |
| G3BP1 SRX24196609 | KGN Gonad | 964 / 11302 (8.5%) | 5136 / 113020 (4.5%) | −65.5 | −63.7 | 1.88 |
Showing first 500 of 18123 rows.